AbstractAPS in pregnancy is one of the important cause of recurrent pregnancy loss, preclampsia and IUGR. Treatment to be started after confirmation of APS with the help of laboratory and clinical criteria. With the imperfect data that are currently available it is impossible to give evidence based recommendations on how patients with APS should be treated in pregnancy. It is wise to regard pregnancies as being at high risk. Treatment to be started with prepregnancy councelling followed by follow up during pregnancy and treatment.
Keywords: APS; Antiphospholipid Antibody (aPL); Recurrent prgnancy loss; Preclampsia.